Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

First it was COVID… now they’re entering cancer #shorts

31 Mar 2026 · 0 min

Watch on YouTube

0:24

In this short, Dr. Dino Prato asks viewers to consider that the mRNA technology that propelled Moderna to fame during the COVID‑19 pandemic is now being applied to create personalized cancer vaccines. He notes Moderna’s partnership with Merck and its strategic shift to rebrand as an oncology company. Prato also raises a controversial claim that the same mRNA platform may have contributed to an aggressive form of cancer—referred to as “turbo cancer”—and suggests this phenomenon could be driving Moderna’s push into the cancer space.

What if I told you the same mRNA platform that made Moderna a household name during the global virus that shut the world down is now being used to build a personalized cancer vaccine? But there's more to it than what we know. Moderna had to partner with Merck. They're trying to rebrand themselves in cancer, and many think the very turbo cancer that may have been caused by this is also why it's fueling them into the cancer space.